Literature DB >> 35040209

Age-Adjusted Serum Neurofilament Predicts Cognitive Decline in Parkinson's Disease (MARK-PD).

Carsten Buhmann1, Susanne Lezius2, Monika Pötter-Nerger1, Christian Gerloff1, Jens Kuhle3, Chi-Un Choe1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35040209     DOI: 10.1002/mds.28909

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  2 in total

1.  Reply to: "Age-Adjusted Serum Neurofilament Predicts Cognitive Decline in Parkinson's Disease (MARK-PD)".

Authors:  Whitley W Aamodt; Alice S Chen-Plotkin
Journal:  Mov Disord       Date:  2022-02       Impact factor: 10.338

Review 2.  Blood-based biomarker in Parkinson's disease: potential for future applications in clinical research and practice.

Authors:  Lars Tönges; Carsten Buhmann; Stephan Klebe; Jochen Klucken; Eun Hae Kwon; Thomas Müller; David J Pedrosa; Nils Schröter; Peter Riederer; Paul Lingor
Journal:  J Neural Transm (Vienna)       Date:  2022-04-15       Impact factor: 3.850

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.